These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12517495)

  • 1. Prevention of coronary artery disease: the south Asian paradox.
    Tunstall-Pedoe S; Starkey C; Mathews B; Hilton S; Cappuccio FP
    Lancet; 2003 Jan; 361(9351):79-80. PubMed ID: 12517495
    [No Abstract]   [Full Text] [Related]  

  • 2. The statin trials: closing arguments in the case against cholesterol?
    Gaw A
    Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy for coronary heart disease: the Sheffield table.
    Wallis EJ; Ramsay LE; Jackson PR; Yeo WW; Williamson R
    Lancet; 1997 Dec 20-27; 350(9094):1852. PubMed ID: 9428275
    [No Abstract]   [Full Text] [Related]  

  • 4. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 5. National cholesterol education program (NCEP) guidelines too complex.
    Feeman WE
    Prev Cardiol; 2005; 8(3):188. PubMed ID: 16108130
    [No Abstract]   [Full Text] [Related]  

  • 6. [AFCAPS/TexCAPS [The Air Force/Texas Coronary Atherosclerosis Prevention Study]].
    Goto Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():398-403. PubMed ID: 11347102
    [No Abstract]   [Full Text] [Related]  

  • 7. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
    Adelman A
    J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward better therapy of hypercholesterolemia.
    Laubach E; Otto C; Schwandt P
    Arch Intern Med; 2000 Sep; 160(17):2685-6. PubMed ID: 10999996
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus conference. Lowering blood cholesterol to prevent heart disease.
    JAMA; 1985 Apr; 253(14):2080-6. PubMed ID: 3974099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 14. High cholesterol levels in healthy seniors: cause for concern?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(1):40-1. PubMed ID: 7770441
    [No Abstract]   [Full Text] [Related]  

  • 15. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 16. [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].
    Homma Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():416-21. PubMed ID: 11347106
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cholesterol question. Disinformed information].
    Bobbio M; Brusca A
    G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy for hypercholesterolemia: guidelines and nursing perspectives.
    Stoy DB
    J Cardiovasc Nurs; 1991 Jan; 5(2):34-43. PubMed ID: 1987332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol-lowering and vascular reactivity in relation to coronary heart disease.
    de Divitiis M; Rubba P
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):133-42. PubMed ID: 10464786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.